Alnylam Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research
Wednesday, January 23, 2019 2:06 PM EDT
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Read
Is Alnylam Pharmaceuticals Finally Ready For Takeoff?
Article By: TipRanks
Thursday, November 15, 2018 7:27 AM EDT
Alnylam is the first major biotech company to focus on RNAi therapies for genetic diseases. This gives the company a leg up, as it faces little competition right now for patents or drug approval.
In this article: ALNY
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EDT
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
Alnylam: Analysts See A Star On The Rise
Article By: TipRanks
Thursday, September 6, 2018 4:37 AM EDT
Biopharma company Alnylam Pharmaceuticals has built a brand on its innovative RNAi therapeutics. Alnylam landed on Forbes’ ‘100 Most Innovative Growth Companies’ list.
In this article: ALNY
Read

PARTNER HEADLINES

Latest Tweets for $ALNY

No tweets yet!